Tributyrin and Constipation: What the Research Shows

No published human trial has tested tributyrin for constipation, so no one can honestly promise it will make you more regular. What exists is a plausible link between butyrate and how the colon moves, mostly from animal and lab studies, plus a handful of human studies of other butyrate forms, largely in people with irritable bowel syndrome (IBS). If you searched for tributyrate for constipation, tributyrin is the standard spelling of the same compound. Here is what the research shows, what it does not, and the options with much stronger evidence for occasional constipation and regularity.

Does tributyrin help with occasional constipation?

It has not been tested. As of this writing, a PubMed search pairing tributyrin with constipation returns a single paper: a 1998 safety study in 13 adults with cancer who took very high doses, 50 to 400 mg per kilogram of body weight a day. For a 70 kilogram adult that is roughly 3.5 to 28 grams a day, far above a supplement serving. Reported side effects included diarrhea, cramping, nausea and, notably, constipation.

Tributyrin is a delivery form of butyrate, three butyrate molecules on a glycerol backbone, so the relevant evidence is butyrate research. Our guide to foods high in butyrate explains where butyrate normally comes from: your own gut bacteria, fermenting fiber.

Why butyrate is linked to gut motility

Researchers connect butyrate to bowel function in several ways. Most of this comes from animal and cell studies, which show mechanisms, not results in people.

• Fuel for colon cells. In a 1980 study of human colon cells from 14 surgical specimens, butyrate supplied about three quarters of the cells' oxygen use when it was the only fuel offered.
• Mucus. In a 2009 study in a human goblet-like cell line, a low concentration of butyrate switched on the gene for MUC2, a key protein of the protective mucus layer. Higher concentrations did not.
• Serotonin signaling. Serotonin made in the gut lining is a key regulator of gut motility and secretion. In a 2015 study, gut bacteria raised colon serotonin in mice, and short-chain fatty acids, the family that includes butyrate, switched on the gene for the serotonin-making enzyme in a human gut-cell model.
• Nerves and muscle. In a 2010 rat study, a resistant-starch diet and butyrate increased the share of acetylcholine-producing gut nerve cells, and the diet sped colon transit. In a 2026 mouse study, sodium butyrate improved stool measures in a drug-induced constipation model.

One human study speaks to comfort rather than motility. In 2009, 11 healthy volunteers used nightly butyrate enemas for a week, and their pain and discomfort scores during a rectal balloon test fell in a dose-dependent way. That was butyrate placed directly in the rectum, not a capsule.

The relationship is not simple. In a 2023 study of 460 women in China, a butyrate-producing bacterium tracked with more frequent bowel movements, yet blood butyrate was higher in women with fewer movements. In the same paper, mouse gut nerve cells in a dish grew best at a moderate butyrate level, not the highest one. More butyrate is not automatically better.

What human studies show for butyrate and constipation

The human evidence is thin. None of these studies tested tributyrin for regularity, and none enrolled people with occasional constipation.

• 2013, 66 adults with IBS. Adding microencapsulated sodium butyrate to standard treatment for 12 weeks reduced pain during bowel movements at 4 weeks and improved urgency and bowel habit at 12 weeks, compared with placebo. The authors concluded it reduced how often some symptoms occurred, without a significant effect on how severe they were.
• 2022, about 3,000 adults with IBS. People taking sodium butyrate, 150 mg twice a day for 12 weeks, reported less pain, gas, diarrhea and constipation. There was no randomization or placebo group, which the authors list as a limitation, and the work was partly sponsored by a pharmaceutical company grant.
• 2025, 51 children with IBS. Calcium butyrate, 500 mg a day (in a tablet that also contained zinc and vitamin D) for 8 weeks, cut pain scores by half or more in 73 percent of children vs about 4 percent on placebo. The groups started with different pain levels, the outcome was pain, and only 15 children had the constipation-predominant type.
• 2025, 17 adults, most with Parkinson disease. In a small open-label study, tributyrin at 500 mg three times a day with food for 30 days was well tolerated; 7 people reported mild, temporary stomach upset or bloating. Bowel habits were not a main outcome.

What this shows: butyrate is being studied for gut comfort, and early results in people with IBS are mixed. What it does not show: that tributyrin, or butyrate in any form, treats or relieves constipation, IBS or any other condition. The 2025 British Dietetic Association guidelines on constipation, built from 75 randomized trials, do not mention butyrate.

What has stronger evidence for occasional constipation

If regularity is your goal, start with the options that have more and better human evidence.

Who should check with a physician first

Occasional constipation is common and usually harmless. See a physician promptly, rather than trying supplements, if you notice:

• Blood in your stool or bleeding from the rectum
• Weight loss without trying
• Severe or constant abdominal pain, vomiting, fever, or being unable to pass gas
• A new, lasting change in bowel habits, especially after age 50. If you are 45 or older and not up to date on colorectal cancer screening, ask about it.
• A family history of colon or rectal cancer, or symptoms that do not improve with self-care

Also talk to your physician before starting tributyrin if you are pregnant or breastfeeding, take prescription medication, or have a diagnosed digestive condition. Constipation that keeps coming back deserves an evaluation, not a supplement trial.

How tributyrin can fit alongside fiber

• Fiber first. It has the evidence, and it is also what your bacteria use to make butyrate.
• Do not expect a laxative. Tributyrin is not a stimulant or a stool softener. If you notice any change in regularity, expect it to be gradual.
• Change one thing at a time. Start with fiber, give it two to three weeks, then add tributyrin, so you can tell which change did what.
• Keep a simple log. Note how often you go and how stools look for a week before and during your trial. Our honest tributyrin timeline explains why 4 to 8 weeks is the fair window.
• Watch for changes when starting. Some people notice looser stools, gas, bloating or other shifts in the first days. Take it with food, as the label directs, and stop and check with your physician if discomfort or loose stools persist. See tributyrin side effects for more.

How Vita Bloom fits

Our Tributyrin is formulated to support digestive comfort and regularity as part of a fiber-rich routine. Each odorless vegetable cellulose capsule provides 550 mg of tributyrin (55 percent), yielding 300 mg of active tributyrin. Take one capsule daily with food, up to two a day, and give it 4 to 8 weeks of consistent use before judging.

Frequently asked questions

Is tributyrin good for occasional constipation?

It has not been tested for constipation in people. Butyrate is linked to gut motility in animal and lab studies, and the few human studies of other butyrate forms in IBS are mixed. Fiber, fluids alongside fiber, and movement have much stronger evidence for occasional constipation.

Can butyrate cause constipation or diarrhea?

Bowel changes in either direction are possible. A 1998 high-dose tributyrin safety study reported both diarrhea and constipation. In a 2025 study at 1,500 mg a day, the reported side effects were mild, temporary stomach upset or bloating in 7 of 17 people.

Is tributyrin a laxative?

No. It is a butyrate supplement that supports the colon lining, not a stimulant or stool softener, and it should not be used in place of a laxative your physician recommends.

Should I take tributyrin with fiber?

Yes. Fiber is the foundation for regularity and the raw material your bacteria use to make butyrate. Add fiber gradually with plenty of fluids, and start the two a few weeks apart.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.